Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iradimed Corp (IRMD)

Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,224,141
  • Shares Outstanding, K 12,721
  • Annual Sales, $ 73,240 K
  • Annual Income, $ 19,230 K
  • EBIT $ 25 M
  • EBITDA $ 26 M
  • 60-Month Beta 1.06
  • Price/Sales 16.91
  • Price/Cash Flow 61.55
  • Price/Book 12.59

Options Overview Details

View History
  • Implied Volatility 28.16% (-1.93%)
  • Historical Volatility 31.31%
  • IV Percentile 8%
  • IV Rank 22.66%
  • IV High 57.32% on 09/11/25
  • IV Low 19.61% on 09/05/25
  • Expected Move (DTE 4) 3.70 (3.81%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 105
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 802
  • Open Int (30-Day) 754
  • Expected Range 93.32 to 100.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.44
  • Number of Estimates 1
  • High Estimate 0.44
  • Low Estimate 0.44
  • Prior Year 0.40
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.25 +16.54%
on 11/17/25
98.44 -1.44%
on 12/11/25
+12.67 (+15.02%)
since 11/14/25
3-Month
67.84 +43.01%
on 09/30/25
98.44 -1.44%
on 12/11/25
+25.41 (+35.48%)
since 09/15/25
52-Week
47.48 +104.35%
on 04/09/25
98.44 -1.44%
on 12/11/25
+44.39 (+84.34%)
since 12/13/24

Most Recent Stories

More News
IRADIMED Announces Special Cash Dividend of $0.50 Per Share

ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”) approved a special cash dividend of $0.50...

IRMD : 97.02 (+0.82%)
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026

ORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative magnetic resonance imaging (MRI)-compatible medical devices, today announced its...

IRMD : 97.02 (+0.82%)
IRadimed: Q3 Earnings Snapshot

IRadimed: Q3 Earnings Snapshot

IRMD : 97.02 (+0.82%)
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results

Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.43 and non-GAAP...

IRMD : 97.02 (+0.82%)
IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025

ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 third quarter financial results before the market opens on...

IRMD : 97.02 (+0.82%)
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director

ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed” or the “Company”) (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”)-compatible...

IRMD : 97.02 (+0.82%)
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference

ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and...

IRMD : 97.02 (+0.82%)
IRadimed: Q2 Earnings Snapshot

IRadimed: Q2 Earnings Snapshot

IRMD : 97.02 (+0.82%)
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results

Announces Regular Quarterly Cash Dividend of $0.17 Per Share Raises Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $20.4 million for the second quarter of 2025, an increase...

IRMD : 97.02 (+0.82%)
IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter financial results before the market opens on...

IRMD : 97.02 (+0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

3rd Resistance Point 99.01
2nd Resistance Point 98.29
1st Resistance Point 97.65
Last Price 97.02
1st Support Level 96.29
2nd Support Level 95.57
3rd Support Level 94.93

See More

52-Week High 98.44
Last Price 97.02
Fibonacci 61.8% 78.97
Fibonacci 50% 72.96
Fibonacci 38.2% 66.95
52-Week Low 47.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar